ENSC Enrolls Patient
Ensysce Biosciences enrolls first patient in final phase of PF614-MPAR-102 clinical study
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Ensysce Biosciences enrolls first patient in final phase of PF614-MPAR-102 clinical study